NCT03237728View on ClinicalTrials.gov

Study of Multiple-dose Kukoamine B Mesilate in Sepsis Patients

PHASE1CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

July 28, 2017

Primary Completion Date

September 25, 2019

Study Completion Date

September 25, 2019

Conditions
Sepsis
Interventions
DRUG

0.06mg/kg,KB

0.06mg/kg,Q8h,Day1-Day7

DRUG

0.12mg/kg,KB

0.12mg/kg,Q8h,Day1-Day7

DRUG

0.24mg/,KB

0.24mg/kg,Q8h,Day1-Day7

DRUG

Placebos

Placebos,Q8h,Day1-Day7

Trial Locations (1)

100730

Peking Union Medical College Hospital, Beijing

All Listed Sponsors
collaborator

Southwest Hospital, China

OTHER

lead

Tianjin Chasesun Pharmaceutical Co., LTD

INDUSTRY

NCT03237728 - Study of Multiple-dose Kukoamine B Mesilate in Sepsis Patients | Biotech Hunter | Biotech Hunter